Navigation Links
CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ
Date:9/26/2007

Study's conclusion of no causal link disputes its own data while several authors' ties to vaccine/pharma defendants spotlight conflicts of interest

NIXA, Mo., Sept. 26 /PRNewswire-USNewswire/ -- The National Autism Association (NAA) says that a CDC study of only 1047 participants, low compliance rate, and very little data variation -- limitations that would ordinarily bar publication in any reputable journal -- appears to misinform the public. They question how such a poor quality study and misleading conclusion can be published in the New England Journal of Medicine (NEJM).

The research conclusion states that findings couldn't support a causal association between early exposure to mercury from thimerosal-containing vaccines and neuropsychological functioning. Yet the data in the body of the paper clearly states a statistically significant relationship between thimerosal and a host of co-morbid disorders frequently seen in autism, replicating earlier CDC findings published in the Nov. 2003 journal Pediatrics.

Contradicting its own conclusion, the NEJM paper states (pgs. 1284-85, 1290) that higher exposure to mercury was associated with:

-- significantly poorer performance on tests of backward recall

-- behavioral regulation problems and a higher likelihood of motor and

phonic tics

-- lower verbal IQ scores

-- speech articulation problems

The study's interpretive outcome and favorable results towards the CDC and vaccine makers might be explained by the exhaustive list of conflicts of interests disclosed by study authors (pg. 1291). "The CDC sets vaccine policy and has ties to vaccine makers, lending bias to any studies they conduct regarding potential vaccine injuries," said NAA board member Scott Bono. "How can Americans expect them to rule against their own policy that advocates injecting excess amounts of a known neurotoxin into children?"

Also, NAA believes that the low compliance rate of 30%, starkly lower than the usual 70% rate in scientific research, might reflect public distrust of the CDC and vaccine safety.

Sallie Bernard, co-founder and executive director of SafeMinds, is a dissenting panel member and the only consumer representative of the study. More commentary on the study can be found at http://www.safeminds.org. To read the study, go to http://www.nejm.org.

Some vaccines and most flu shots still contain a toxic mix of mercury and aluminum.

For more information about autism, go to http://www.nationalautism.org.

Contact: Wendy Fournier

401-632-7523

Rita Shreffler

401-632-6452


'/>"/>
SOURCE National Autism Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: